Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Kabra Drugs

Sector: Healthcare | Industry: Drugs & Pharma
R 0.70 0.03  | 4.48% - - 0.31
BSE Price: Oct 17, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 17, 2019 0.70 0.03 4.48% 0.70 0.67 168 0.70 - 0.70
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 739 P/B: 1.65 NSE Code:
52-Week Range: R 0.52 - 1.89 Dividend Yield: 0.00% BSE Code: 524322
TTM EPS: R -0.02 Book Value: R 0.43 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Kabra Drugs -4.11 - - - -51.82 -54.88 -
S&P BSE Small Cap -12.19 0.46 -5.85 -9.51 -0.50 4.60 5.21
S&P BSE Healthcare -10.20 -2.68 -4.93 -14.60 -7.95 -1.47 10.83
Company's return has been calculated on basis of BSE's price.
As on Oct 17, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -76.31 -39.80 -29.29
Net Profit -1,909.98 -422.09 -273.83
EPS -1,909.98 -422.09 -273.83
Book Value -92.30 -57.74 -41.40
Average
Operating Margin -56.62 -14.82 -6.96
Net Margin -129.86 -42.63 -25.26
Return on Networth -171.40 -55.11 -31.96
Return on Investment -80.09 -22.26 -11.69
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - - -
Operating Profit 83.33 - 99.77
Net Profit 83.33 - 99.94
EPS 83.21 - 99.93
TTM
Revenue - -100.00 -100.00
Operating Profit -10.00 99.07 99.02
Net Profit -11.11 99.58 99.57
EPS -11.17 99.57 99.57
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Aug 03, 2016 Ayush Kabra  Sell Inter-Se Transfer 222,000 7.60 16.87
Aug 03, 2016 Ayush Kabra  Buy Inter-Se Transfer 222,000 7.60 16.87
Oct 29, 2014 Shyam Kabra  Sell Market 20,000 42.90 8.58
Oct 23, 2014 Shyam Kabra  Sell Off Market 10,000 40.50 4.05
Oct 20, 2014 Shyam Kabra  Sell Market 25,000 38.25 9.56
News & Announcements
Contact Information

Company: Kabra Drugs Ltd.

Address: Shop No 270, Shastri Market, Indore, Madhya Pradesh - 452001 | Phone: 0731- 2722756/ 2721305 | Fax: 0731- 2722756

Email: [email protected]/[email protected]

Website: www.kabradrugslimited.com

Registrar & Transfer Agent: Ankit Consultancy Pvt Ltd

Address: Plot No. 60, Electronic Complex, Pardeshipura, Indore (M.P.)-452010, Plot No 60, Electronic Complex, Pardeshipura

Essential checks
Altman Z-Score
-3.37
Piotroski F-Score
2
Modified C-Score
5
5-Years Price to Earnings
Not applicable
5-Years Price to Book
1.65
Earnings Yield
EBIT / Enterprise value
-1.24%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,299.25 +4.57%
Caplin Point Laboratories R394.45 -2.30%
Eris Lifesciences R416.05 -0.22%
FDC R161.35 +0.62%
JB Chemicals & Pharma R359.25 +0.45%
Laurus Labs R310.25 -0.80%
Strides Pharma Science R353.85 +0.78%
Sun Pharma Adv. Research R130.70 +1.32%
Suven Life Sciences R264.80 +1.83%
Wockhardt R259.20 +1.29%
As on Oct 17, 16:00